Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” The grants were awarded to Jennifer Pietenpol, Ph.D., director of VICC, and the My Cancer Genome project, developed by Mia Levy, M.D., Ph.D., assistant professor of Medicine and Biomedical Informatics, and William Pao, M.D., Ph.D., [...]

The National Cancer Institute has renewed a $4.4 million, five-year grant to fund training for senior fellows and junior faculty for careers in cancer-oriented research. The goal of the Vanderbilt Clinical Oncology Research Career Development Program is to train clinician scientists who can design and implement clinical oncology trials and lead translational research projects. The [...]

  Yong Cha, M.D., Ph.D., a Radiation Oncology resident at Vanderbilt University Medical Center, has received a $25,000 grant from the American Society for Radiation Oncology (ASTRO) to help fund his research on the genetic underpinnings of cancer cells. The Residents/Fellows in Radiation Oncology Research Seed Grant Award is given to support residents or fellows [...]

The National Center for Research Resources has awarded Vanderbilt University $10.3 million over the next five years to establish a National Research Resource for Imaging Mass Spectrometry. Richard Caprioli, Ph.D., director of Vanderbilt’s Mass Spectrometry Research Center, is leading the program. Imaging mass spectrometry is a tool for visualizing the location of proteins in cells [...]

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The findings, reported in two papers in the Proceedings of the National Academy of Sciences (PNAS), suggest that upregulation of the HER3 receptor limits the effectiveness of two classes [...]

Uniting Against Lung Cancer, a nonprofit organization dedicated to funding innovative lung cancer research in the United States and Canada, has awarded a $100,000 grant to Christine Lovly, M.D., Ph.D., a fellow in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center. The two-year grant will fund Lovly’s research on better treatment options for a subset [...]

Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, has received a $2.5 million grant to fund research on drugs for the treatment of pancreatic cancer. The three-year award from the Lustgarten Foundation will support Fesik’s work on targeting K-Ras, a protein that is mutated in 90 percent of pancreatic cancer patients. Approximately 43,140 patients [...]

Vanderbilt-Ingram Cancer Center has been awarded a five-year renewal of its Cancer Center Support Grant (CCSG) from the National Cancer Institute. Under the NCI’s Cancer Center Support Grant Program, VICC will receive more than $6.2 million per year for the next five years. The total represents a 12.7 percent increase over the previous award. The [...]

The National Institute of General Medical Sciences has awarded a 5-year, $22.5 million “glue grant” to an international team of scientists who will investigate how the structure and movement (structural dynamics) of membrane proteins determine their functions, which range from generating cellular energy to helping hold cells in a tissue together. The funding establishes the [...]

Stephen Fesik, Ph.D., has been awarded a National Institutes of Health Director’s Pioneer Award for his proposal to push the boundaries of drug discovery. Fesik, the Orrin H. Ingram II Chair in Cancer Research, is the first investigator from Vanderbilt to receive this coveted award. The 17 researchers honored this year join the 81 other [...]